CS 8958: Clinical Trials

5 trials of CS 8958, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 3 Phase 1, 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 22Completed 1, Terminated 1
Phase 31Completed 1

Follow CS 8958: new trials by email Literature Review of CS 8958 trials Research Report on CS 8958

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza
20 mg laninamivir octanoate, Placebo, 40 mg laninamivir octanoate - Influenza
Phase 1 / Phase 2TerminatedBiota Scientific Management Pty Ltd152013-11-012025-01-13
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma
Laninamivir octanoate - Asthma
Phase 1CompletedBiota Scientific Management Pty Ltd322013-10-012018-05-30
Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza
40 mg Laninamivir Octanoate, 80 mg Laninamivir Octanoate, Placebo - Influenza
Phase 2CompletedBiota Scientific Management Pty Ltd6392013-05-012018-05-31
Safety, Tolerability and Pharmacokinetic Study of Multiple Doses of CS-8958
CS-8958, Placebo - Influenza
Phase 1CompletedBiota Scientific Management Pty Ltd162009-04-012018-05-30
A Multinational Phase III Study of CS-8958 (MARVEL)
CS-8958, oseltamivir phosphate - Influenza, Human
Phase 3CompletedDaiichi Sankyo Co., Ltd.10022008-11-012019-01-09

Conditions studied

Influenza, Human (4)  ·  Asthma (1)  ·  Lymphoma, Follicular (1)

Sponsors

Biota Scientific Management Pty Ltd (4)  ·  Daiichi Sankyo Co., Ltd. (1)

Countries

United Kingdom (3)  ·  United States (2)  ·  Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Colombia (1)  ·  Estonia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Japan (1)  ·  Latvia (1)  ·  Mexico (1)

Top investigators

Jolanta Airey, Dr (2)  ·  Jane Ryan, PhD (1)  ·  John Lambert, PhD (1)

Results publications

PMID 20936975

NIH funding

1UC1AI062373-01 (1), 2008 (1)